article thumbnail

Medicare moving to reference pricing?

Healthcare ECONOMIST

“CMS will exclude a drug or biological product that is designated as a drug for only one rare disease or condition under section 526 of the FD&C Act and that is approved for only an indication (or indications) for such disease or condition” Low-spending Medicare drugs. Note that this figure is not inflation indexed.

Medicare 111
article thumbnail

Major Questions about Vaccine Mandates, the Supreme Court, and the Major Questions Doctrine

Bill Of Health

This Friday, the Supreme Court will hear arguments about two federal vaccine mandates: the Centers for Medicare and Medicaid Services’ (CMS) mandate for health care workers, and the Occupational Safety and Health Administration’s (OSHA) vaccine-or-test mandate for employers with over 100 workers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Sheppard Health Law

The Rebate Programs are administered as part of the prescription drug affordability provisions of the Inflation Reduction Act (the “IRA”), which is aimed at “lower[ing] out-of-pocket drug costs for people with Medicare and improv[ing] the sustainability of the Medicare program for current and future generations.” [1]

article thumbnail

Assessing the Potential Impact of Commercialization of COVID-19 Vaccines on Vaccine Access

NASHP

Increased Cost Barriers for Underinsured and Uninsured Populations Traditionally, vaccines in the United States are paid for in one of three ways — through an individual’s private insurance plan; through publicly-funded programs such as Medicare, Medicaid, and the Vaccines for Children (VFC) program; or directly by consumers.

Medicaid 105
article thumbnail

340B Court Cases

Healthcare ECONOMIST

The Public Health Service Act ( PHSA ) in 1992, created a program to allow hospitals providing care for underserved communities to be able to access discounted drugs. Becerra v Empire Health Foundation. This case examines how Medicare calculates disproportionate share hospital (DSH) payments to hospitals.

article thumbnail

NASHP Model Act to Limit Out-of-Network Provider Rates

NASHP

This model legislation limits out-of-network rates for inpatient and outpatient hospital services to the lesser of (a) the state’s median in-network commercial rate for the same service; or (b) [X]% of the Medicare rate for the same service in the same geographic area.

article thumbnail

CMS Administrator Brooks-LaSure Letter to Payors Regarding Coverage of COVID-19 Vaccines Post Commercialization

Briggs Healthcare

We also wanted to send these reminders from the Centers for Medicare & Medicaid Services (CMS) about COVID-19 vaccine coverage and encourage you to start planning now for the fall vaccination campaign. By law, any Food and Drug Administration (FDA)-approved or authorized COVID-19 vaccine is covered under Medicare Part B.